| Product Code: ETC6746315 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The China levodopa import market experienced significant growth in 2024, with Ireland, Germany, Switzerland, USA, and India emerging as the top exporting countries. The market concentration, as measured by the HHI, escalated from moderate to very high in just one year, reflecting a notable shift in market dynamics. The impressive compound annual growth rate (CAGR) of 27.42% from 2020 to 2024, coupled with a remarkable growth rate of 200.67% from 2023 to 2024, underscores the robust demand for levodopa in China and the increasing competitiveness among the key exporting nations.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Levodopa Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Levodopa Market Revenues & Volume, 2021 & 2031F |
3.3 China Levodopa Market - Industry Life Cycle |
3.4 China Levodopa Market - Porter's Five Forces |
3.5 China Levodopa Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 China Levodopa Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 China Levodopa Market Revenues & Volume Share, By Distribution Channels, 2021 & 2031F |
4 China Levodopa Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in China |
4.2.2 Growing awareness about the benefits of levodopa in managing Parkinson's symptoms |
4.2.3 Technological advancements in drug delivery systems for levodopa |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in China |
4.3.2 Potential side effects and complications associated with long-term levodopa use |
5 China Levodopa Market Trends |
6 China Levodopa Market, By Types |
6.1 China Levodopa Market, By Form |
6.1.1 Overview and Analysis |
6.1.2 China Levodopa Market Revenues & Volume, By Form, 2021- 2031F |
6.1.3 China Levodopa Market Revenues & Volume, By Tablets, 2021- 2031F |
6.1.4 China Levodopa Market Revenues & Volume, By Capsules, 2021- 2031F |
6.1.5 China Levodopa Market Revenues & Volume, By Powder, 2021- 2031F |
6.1.6 China Levodopa Market Revenues & Volume, By Liquid, 2021- 2031F |
6.2 China Levodopa Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 China Levodopa Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 China Levodopa Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3 China Levodopa Market, By Distribution Channels |
6.3.1 Overview and Analysis |
6.3.2 China Levodopa Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 China Levodopa Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 China Levodopa Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.5 China Levodopa Market Revenues & Volume, By Other, 2021- 2031F |
7 China Levodopa Market Import-Export Trade Statistics |
7.1 China Levodopa Market Export to Major Countries |
7.2 China Levodopa Market Imports from Major Countries |
8 China Levodopa Market Key Performance Indicators |
8.1 Number of new diagnoses of Parkinson's disease in China |
8.2 Adoption rate of levodopa as a primary treatment for Parkinson's disease |
8.3 Research and development investment in improving levodopa formulations and delivery systems |
9 China Levodopa Market - Opportunity Assessment |
9.1 China Levodopa Market Opportunity Assessment, By Form, 2021 & 2031F |
9.2 China Levodopa Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 China Levodopa Market Opportunity Assessment, By Distribution Channels, 2021 & 2031F |
10 China Levodopa Market - Competitive Landscape |
10.1 China Levodopa Market Revenue Share, By Companies, 2024 |
10.2 China Levodopa Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |